{
    "Trade/Device Name(s)": [
        "S-Test Hemoglobin A1c Reagent cartridge",
        "S-Test % Hemoglobin A1c (HbA1c)"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K091711",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071466",
        "K951361"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "November 24, 2009",
    "Summary Letter Received Date": "November 25, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "EDTA whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "S40 Clinical Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay",
        "Enzymatic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for S-Test Hemoglobin A1c reagent cartridges for quantitative HbA1c measurement using colorimetric and enzymatic assays on the S40 Clinical Analyzer.",
    "Indications for Use Summary": "Quantitative determination of percent Hemoglobin A1c concentration in EDTA whole blood using the S40 Clinical Analyzer to monitor long-term glycemic control in individuals with diabetes in clinical and physician office laboratories.",
    "fda_folder": "Hematology"
}